NCT03559166View on ClinicalTrials.gov

First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis

PHASE1CompletedINTERVENTIONAL

Enrollment

88

Participants

Timeline

Start Date

July 11, 2018

Primary Completion Date

October 4, 2019

Study Completion Date

October 4, 2019

Conditions

Fibrosis

Interventions

DRUG

BLD-2660

Randomized to active product or placebo

Trial Locations (1)

3004

Nucleus Network, Melbourne

Sponsors

Lead Sponsor

Blade Therapeutics

All Listed Sponsors

lead

Blade Therapeutics

INDUSTRY

NCT03559166 - First in Human Study in Healthy Volunteers Followed With Dosing in Participants With Lung or Liver Fibrosis | Biotech Hunter | Biotech Hunter